secwatch / observer

8-K filed February 10, 2026, 6:59 PM ET ticker CAQ CIK 0002100125

other material confidence high sentiment neutral materiality 0.75

SPAC Cambridge Acquisition closes $230M IPO; proceeds placed in trust for business combination

Cambridge Acquisition Corp.

Closed IPO of 23M units at $10/unit, gross proceeds $230M (including full over-allotment exercise).
Simultaneous private placement of 495,500 units to sponsor at $10/unit for $4.955M.
Net proceeds of $230M from IPO and private placement deposited in trust account for future business combination.
Units began trading Feb. 6 on Nasdaq under ticker CAQUU; ordinary shares CAQ, warrants CAQUW expected to trade separately later.

item 1.01 item 3.02 item 5.03 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-012751
form_type: 8-K
ticker: CAQ
cik: 0002100125
company_name: Cambridge Acquisition Corp.
filed_at: 2026-02-10T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.262601+00:00
generated_at: 2026-05-16T03:41:52.613368+00:00
sec_items: ["1.01", "3.02", "5.03", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-012751
json_url: https://secwatch.observer/filing/0001104659-26-012751.json
markdown_url: https://secwatch.observer/filing/0001104659-26-012751.md
text_url: https://secwatch.observer/filing/0001104659-26-012751.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2100125/000110465926012751/0001104659-26-012751-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2100125/000110465926012751/tm265727d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

2d74774eb48d907336006a6896d5dd7f1b4f48d3

Cambridge Acquisition Corp.: Adopted Amended and Restated Memorandum and Articles of Association in connection with IPO (effective 2026-02-09).

On February 9, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

2bd109483d51a7508d75731dd5ce59145445fec6

Cambridge Acquisition Corp. entered into Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-05).

Warrant Agreement, dated as of February 5, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

977b1d3a9c6d1d9e939053da2034837a7bac363b

Cambridge Acquisition Corp. entered into Underwriting Agreement with BTIG, LLC valued at $230,000,000 (effective 2026-02-05).

Underwriting Agreement, dated February 5, 2026, by and between the Company and BTIG, LLC, as representative of the underwriters

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

9ba2a829911f46394940b3c9a8fdf307af30d236

Cambridge Acquisition Corp. entered into Private Units Subscription Agreement with Cambridge Sponsor LLC (effective 2026-02-05).

· Letter Agreement, dated February 5, 2026, by and among the Company, Cambridge Sponsor LLC (the “Sponsor”), the initial shareholders and the officers and directors of the Company, a copy of which is attached as Exhibit 10.1 and incorporated herein by reference; · Investment Management Trust Agreement, dated as of February 5, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.2 and incorporated herein by reference; · Registration Rights Agreement, dated as of February 5, 2026, by and among the Company and certain security holders of the Company, a copy of which is attached as Exhibit 10.3 and incorporated herein by reference; · Private Units Subscription Agreement, dated February 5, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by ref

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

aaf411d88a50c50aa2cc4b8ae45681c6c47d331f

Cambridge Acquisition Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-05).

Investment Management Trust Agreement, dated as of February 5, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

d6651a83aac01158e09340261d9dee7c1b98a346

Cambridge Acquisition Corp. entered into Registration Rights Agreement with certain security holders of the Company (effective 2026-02-05).

Registration Rights Agreement, dated as of February 5, 2026, by and among the Company and certain security holders of the Company

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 3.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On February 9, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.

Filing page SEC filing

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 3.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On February 9, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Filing page SEC filing

CLRB

Cellectar raises ~$35M via stock/warrant offering; reports positive 12-mo Phase 2b WM data

Cellectar Biosciences, Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 8.01, 9.01 same event type: other_material similar materiality

This filing

Warrant Agreement, dated as of February 5, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent

Comparable filing

pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement”

Filing page SEC filing

PSEC

Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares

PROSPECT CAPITAL CORP May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 9.01 same event type: other_material similar materiality

This filing

On February 9, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.

Filing page SEC filing

TPST

Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73

Tempest Therapeutics, Inc. June 1, 2026, 7:13 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

Warrant Agreement, dated as of February 5, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent

Comparable filing

On May 28, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into a warrant exercise and inducement offer letter agreement (the “ Inducement Letter ”) with a holder of certain existing warrants to purchase shares of the Company’s common stock

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 8.01, 9.01 same event type: other_material similar materiality

This filing

Warrant Agreement, dated as of February 5, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent

Comparable filing

On May 28, 2026, Karman Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the persons named in Schedule II thereto (the “Selling Stockholders”) and Citigroup Global Markets Inc. and Evercore Group L.L.C., as the underwriters (the “Underwriters”), pursuant to which the Selling Stockholders agreed to sell 14,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a public offering price of $61.00 per share (the “Offering Price”), less underwriting discounts and commissions (the “Offering”).

Filing page SEC filing

XRN

Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP

Chiron Real Estate Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

Warrant Agreement, dated as of February 5, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent

Comparable filing

In connection with the Private Placement, on May 6, 2026, the Company and the Purchasers entered an Investor Rights Agreement.

Filing page SEC filing

PBT

Court approves trust indenture amendments eliminating 75% supermajority requirement

PERMIAN BASIN ROYALTY TRUST May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 5.03, 9.01 same event type: other_material similar materiality

This filing

Warrant Agreement, dated as of February 5, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent

Comparable filing

Argent Trust Company, the trustee of the Trust, entered into Amendment No. 2 to the Amended and Restated Trust Indenture of Permian Basin Royalty Trust dated May 8, 2026 (the “Amendment”) implementing the modifications approved by the Court.

Filing page SEC filing

Source: SEC EDGAR

accession 0001104659-26-012751

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.